CMS change brings uncertainty for Genomic Health, says Piper Jaffray Piper Jaffray says said it recently uncovered changes in the CMS Medicare Administrative Contractor for California, with Noridian winning the Jurisdiction E contract from current provider Palmetto. Piper expects little near-term impact to Genomic Health's Oncotype breast and colon assays from the change, but feels it introduces potential reimbursement uncertainty longer term. Piper keeps an Overweight rating on Genomic Health.
News For GHDX From The Last 14 Days
Check below for free stories on GHDX the last two weeks.